The PET-derived tumor-to-blood standard uptake ratio SUR is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDGReportar como inadecuado

The PET-derived tumor-to-blood standard uptake ratio SUR is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

EJNMMI Research

, 3:77

First Online: 23 November 2013Received: 09 September 2013Accepted: 04 November 2013DOI: 10.1186-2191-219X-3-77

Cite this article as: van den Hoff, J., Oehme, L., Schramm, G. et al. EJNMMI Res 2013 3: 77. doi:10.1186-2191-219X-3-77


BackgroundThe standard uptake value SUV approach in oncological positron emission tomography has known shortcomings, all of which affect the reliability of the SUV as a surrogate of the targeted quantity, the metabolic rate of Ffluorodeoxyglucose FDG, Km. Among the shortcomings are time dependence, susceptibility to errors in scanner and dose calibration, insufficient correlation between systemic distribution volume and body weight, and, consequentially, residual inter-study variability of the arterial input function AIF despite SUV normalization. Especially the latter turns out to be a crucial factor adversely affecting the correlation between SUV and Km and causing inter-study variations of tumor SUVs that do not reflect actual changes of the metabolic uptake rate. In this work, we propose to replace tumor SUV by the tumor-to-blood standard uptake ratio SUR in order to distinctly improve the linear correlation with Km.

MethodsAssuming irreversible FDG kinetics, SUR can be expected to exhibit a much better linear correlation to Km than SUV. The theoretical derivation for this prediction is given and evaluated in a group of nine patients with liver metastases of colorectal cancer for which 15 fully dynamic investigations were available and Km could thus be derived from conventional Patlak analysis.

ResultsFor any fixed time point T at sufficiently late times post injection, the Patlak equation predicts a linear correlation between SUR and Km under the following assumptions: 1 approximate shape invariance but arbitrary scale of the AIF across scans-patients and 2 low variability of the apparent distribution volume Vr the intercept of the Patlak Plot. This prediction - and validity of the underlying assumptions - has been verified in the investigated patient group. Replacing tumor SUVs by SURs does improve the linear correlation of the respective parameter with Km from r = 0.61 to r = 0.98.

ConclusionsSUR is an easily measurable parameter that is highly correlated to Km. In this respect, it is clearly superior to SUV. Therefore, SUR should be seriously considered as a drop-in replacement for SUV-based approaches.

KeywordsSUV Tumor-to-blood ratio PET PET-CT Therapy response control FDG Electronic supplementary materialThe online version of this article doi:10.1186-2191-219X-3-77 contains supplementary material, which is available to authorized users.

Download fulltext PDF

Autor: Jörg van den Hoff - Liane Oehme - Georg Schramm - Jens Maus - Alexandr Lougovski - Jan Petr - Bettina Beuthien-Baumann - F


Documentos relacionados